BCHE and Dravet syndrome: However, choline esterase inhibitors have not been extensively used in patients with DS-related AD, due to side effects that might interfere with and contribute to comorbidities, even after a recent study suggested that patients with DS–AD could benefit from cholinesterase inhibitors [101].